Abstract:Effective strategies are needed to deal with invasive fungal infections caused by drug-resistant fungi. Previously, we designed a series of antifungal benzocyclane derivatives based on the drug repurposing of haloperidol. Herein, further structural optimization and antifungal mechanism studies were performed, leading to the discovery of new piperidol derivative B2 with improved synergistic antifungal potency, selectivity, and water solubility. In particular, the combination of compound B2 and fluconazole showed potent in vitro and in vivo antifungal activity against azole-resistant Candida albicans. Compound B2 inhibited important virulence factors by regulating virulence-associated genes and improved the efficacy of fluconazole by down-regulating the CYP51-coding gene and efflux pump gene. Taken together, the piperidol derivative B2 represents a promising lead compound for the combinational treatment of azole-resistant candidiasis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsinfecdis.0c00849?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00849</a>.Discussions of strains, culture, and agents used, mature biofilm destruction assay, real-time RT-PCR analysis, HTRF assay, water solubility test, and chemical synthesis and structural characterization, figures of biofilm formation percentages compared to the untreated groups, dose response curves, 1H and 13C NMR spectra, ESI-HRMS spectra, and HPLC spectra, table of primers for real-time RT-PCR, and schemes of synthetic pathways (<a class="ext-link" href="/doi/suppl/10.1021/acsinfecdis.0c00849/suppl_file/id0c00849_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis

Discovery of Novel Fungal Lanosterol 14-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis

Lanosterol 14Α-Demethylase (cyp51)/histone Deacetylase (HDAC) Dual Inhibitors for Treatment of Candida Tropicalis and Cryptococcus Neoformans Infections.

Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.

Heat Shock Protein 90 (hsp90)/histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Azoles-Resistant Candida Albicans.

Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance

Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity Against Fluconazole-Resistant Candida Albicans.

Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis

Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Structure-based Virtual Screening and ADME/T-based Prediction Analysis for the Discovery of Novel Antifungal CYP51 Inhibitors.

New azoles with potent antifungal activity: design, synthesis and molecular docking.

Design, Synthesis, and Biological Evaluation of Dual-Target COX-2/CYP51 Inhibitors for the Treatment of Fungal Infectious Diseases.

Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi.

Discovery of Pyrazolone Carbothioamide Derivatives As Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis.

Design, Synthesis and Bioactivity Evaluation of Novel Arylalkene-Amide Derivatives As Dual-Target Antifungal Inhibitors

Design, Synthesis, and Antifungal Activities of Novel 1H-Triazole Derivatives Based on the Structure of the Active Site of Fungal Lanosterol 14α-Demethylase (CYP51)

Azole-triphenylphosphonium Conjugates Combat Antifungal Resistance and Alleviate the Development of Drug-Resistance

Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies

Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans.

Discovery of Highly Potent Antifungal Triazoles by Structure-Based Lead Fusion